Microwave-accelerated synthesis of p1′-extended HIV-1 protease inhibitors encompassing a tertiary alcohol in the transition-state mimicking scaffold

被引：41

作者：

Ekegren, JK

Ginman, N

Johansson, Å

Wallberg, H

Larhed, M

Samuelsson, B

Unge, T

Hallberg, A

机构：

[1] Uppsala Univ, Dept Med Chem, BMC, SE-75123 Uppsala, Sweden

[2] Uppsala Univ, Dept Cell & Mol Biol, BMC, SE-75124 Uppsala, Sweden

[3] Medivir AB, SE-14144 Huddinge, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 05期

关键词：

D O I：

10.1021/jm051239z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Two series of P1'-extended HIV-1 protease inhibitors comprising a tertiary alcohol in the transition-state mimic exhibiting K-i values ranging from 2.1 to 93 nM have been synthesized. Microwave-accelerated palladium-catalyzed cross-couplings were utilized to rapidly optimize the P1' side chain. High cellular antiviral potencies were encountered when the P1' benzyl group was elongated with a 3- or 4-pyridyl substituent (EC50 = 0.18-0.22 mu M). X-ray crystallographic data were obtained for three inhibitors cocrystallized with the enzyme.

引用

页码：1828 / 1832

页数：5

共 39 条

[31] BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents
Robinson, BS
Riccardi, KA
Gong, YF
Guo, Q
Stock, DA
Blair, WS
Terry, BJ
Deminie, CA
Djang, F
Colonno, RJ
Lin, PF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2093 - 2099
[32] HIV protease inhibition:: Limited recent progress and advances in understanding current pitfalls
Rodríguez-Barrios, F
Gago, F
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 991 - 1007
[33] SAVIN VI, 1992, ZH ORG KHIM+, V28, P43
[34] Sonogashira K., 2002, Handbook of Organopalladium Chemistry for Organic Synthesis, P493
[35] Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors
Thaisrivongs, S
Romero, DL
Tommasi, RA
Janakiraman, MN
Strohbach, JW
Turner, SR
Biles, C
Morge, RR
Johnson, PD
Aristoff, PA
Tomich, PK
Lynn, JC
Horng, MM
Chong, KT
Hinshaw, RR
Howe, WJ
Finzel, BC
Watenpaugh, KD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) : 4630 - 4642
[36] Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class
Turner, SR
Strohbach, JW
Tommasi, RA
Aristoff, PA
Johnson, PD
Skulnick, HI
Dolak, LA
Seest, EP
Tomich, PK
Bohanan, MJ
Horng, MM
Lynn, JC
Chong, KT
Hinshaw, RR
Watenpaugh, KD
Janakiraman, MN
Thaisrivongs, S
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3467 - 3476
[37] L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
VACCA, JP
DORSEY, BD
SCHLEIF, WA
LEVIN, RB
MCDANIEL, SL
DARKE, PL
ZUGAY, J
QUINTERO, JC
BLAHY, OM
ROTH, E
SARDANA, VV
SCHLABACH, AJ
GRAHAM, PI
CONDRA, JH
GOTLIB, L
HOLLOWAY, MK
LIN, J
CHEN, IW
VASTAG, K
OSTOVIC, D
ANDERSON, PS
EMINI, EA
HUFF, JR
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4096 - 4100
[38] High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations
Wannberg, J
Kaiser, NFK
Vrang, L
Samuelsson, B
Larhed, M
Hallberg, A
[J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2005, 7 (04): : 611 - 617
[39] The effect of increasing α1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors
Zhang, XQ
Schooley, RT
Gerber, JG
[J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) : 1833 - 1837

← 1 2 3 4 →